Sacré, Anne, Philippe Barthélémy, Clement Korenbaum, Mickael Burgy, Pascal Wolter, Herlinde Dumez, Evelyne Lerut, et al. “Prognostic Factors in Second-Line Targeted Therapy for Metastatic Clear-Cell Renal Cell Carcinoma After Progression on an Anti-Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor”. Acta Oncologica 55, no. 3 (March 3, 2016): 329–340. Accessed July 30, 2024. https://medicaljournalssweden.se/actaoncologica/article/view/25233.